Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
about
Monitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studiesGeneration and screening of monoclonal antibodies for immunoPET imaging of IGF1R in prostate cancer.18F-FLT and 18F-FDG PET-CT imaging in the evaluation of early therapeutic effects of chemotherapy on Walker 256 tumor-bearing rats.PI3K pathway inhibition in GBM—is there a signal?Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug.Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma.
P2860
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@en
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@nl
type
label
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@en
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@nl
prefLabel
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@en
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@nl
P2093
P2860
P1476
Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.
@en
P2093
Ambros J Beer
Andreas K Buck
Annette Feuchtinger
Axel Walch
Kathrin Philipp-Abbrederis
Kelsey L Pomykala
Ken Herrmann
Klemens Scheidhauer
Markus Schwaiger
Martin Henninger
P2860
P577
2013-12-15T00:00:00Z